Charles A. Thornton

18.4k total citations · 3 hit papers
157 papers, 13.7k citations indexed

About

Charles A. Thornton is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Charles A. Thornton has authored 157 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Molecular Biology, 109 papers in Cellular and Molecular Neuroscience and 37 papers in Neurology. Recurrent topics in Charles A. Thornton's work include Genetic Neurodegenerative Diseases (106 papers), Muscle Physiology and Disorders (55 papers) and Mitochondrial Function and Pathology (45 papers). Charles A. Thornton is often cited by papers focused on Genetic Neurodegenerative Diseases (106 papers), Muscle Physiology and Disorders (55 papers) and Mitochondrial Function and Pathology (45 papers). Charles A. Thornton collaborates with scholars based in United States, Canada and Poland. Charles A. Thornton's co-authors include Stephen Welle, Richard T. Moxley, Maurice S. Swanson, Ami Mankodi, Thurman M. Wheeler, Krzysztof Sobczak, Masayuki Nakamori, Robert J. Osborne, Kirti Bhatt and Rahul Kanadia and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Charles A. Thornton

154 papers receiving 13.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Muscleblind Knockout Model for Myotonic Dystrophy

2003 576 citations Rahul Kanadia, Karen A. Johnstone et al. Science profile →
Myotonic Dystrophy in Transgenic Mice Expressing an Expanded CUG Repeat

2000 554 citations Ami Mankodi, Carolyn McClain et al. Science profile →
Expanded CUG Repeats Trigger Aberrant Splicing of ClC-1 Chloride Channel Pre-mRNA and Hyperexcitability of Skeletal Muscle in Myotonic Dystrophy

2002 513 citations Ami Mankodi, Richard T. Moxley et al. profile →

Peers

Countries citing papers authored by Charles A. Thornton

Since Specialization

Citations

This map shows the geographic impact of Charles A. Thornton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles A. Thornton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles A. Thornton more than expected).

Fields of papers citing papers by Charles A. Thornton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles A. Thornton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles A. Thornton. The network helps show where Charles A. Thornton may publish in the future.

Co-authorship network of co-authors of Charles A. Thornton

This figure shows the co-authorship network connecting the top 25 collaborators of Charles A. Thornton. A scholar is included among the top collaborators of Charles A. Thornton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles A. Thornton. Charles A. Thornton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trial	PLoS ONE	Anneli Cooper, Sarah A. Cumming et al.	12
2	Intron retention induced by microsatellite expansions as a disease biomarker	Proceedings of the National Academy of Sciences	Łukasz J. Sznajder, James D. Thomas et al.	83
3	High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2	Neurology	James E. Hilbert, Richard J. Barohn et al.	37
4	Dose-Dependent Regulation of Alternative Splicing by MBNL Proteins Reveals Biomarkers for Myotonic Dystrophy	PLoS Genetics	Stacey D. Wagner, Adam J. Struck et al.	73
5	Dmpkgene deletion or antisense knockdown does not compromise cardiac or skeletal muscle function in mice	Human Molecular Genetics	Ellie M. Carrell, David S. Auerbach et al.	41
6	Detection of Slipped-DNAs at the Trinucleotide Repeats of the Myotonic Dystrophy Type I Disease Locus in Patient Tissues	PLoS Genetics	Michelle M. Axford, Yuh‐Hwa Wang et al.	48
7	Diagnostic odyssey of patients with myotonic dystrophy	Journal of Neurology	James E. Hilbert, Tetsuo Ashizawa et al.	72
8	Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy	Neurobiology of Disease	Ami Mankodi, Thurman M. Wheeler et al.	17
9	Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA	Science	Thurman M. Wheeler, Krzysztof Sobczak et al.	303
10	Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy	Proceedings of the National Academy of Sciences	Susan Mulders, Walther J. A. A. van den Broek et al.	204
11	Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1	Neuromuscular Disorders	Thurman M. Wheeler, Charles A. Thornton et al.	44
12	Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy	Neurology	Robert J. Osborne, Stephen Welle et al.	112
13	Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy	Proceedings of the National Academy of Sciences	Rahul Kanadia, Jihae Shin et al.	274
14	Muscle growth after postdevelopmental myostatin gene knockout	American Journal of Physiology-Endocrinology and Metabolism	Stephen Welle, Kirti Bhatt et al.	87
15	A Muscleblind Knockout Model for Myotonic Dystrophy breakdown →	Science	Rahul Kanadia, Karen A. Johnstone et al.	576
16	Inventory of High-Abundance mRNAs in Skeletal Muscle of Normal Men	Genome Research	Stephen Welle, Kirti Bhatt et al.	98
17	Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene	Nature Genetics	Charles A. Thornton, James Wymer et al.	174
18	Effect of age on muscle hypertrophy induced by resistance training	The Journals of Gerontology Series A	Stephen Welle, Saara Tötterman et al.	147
19	Myotonic dystrophy with no trinucleotide repeat expansion	Annals of Neurology	Charles A. Thornton, Robert C. Griggs et al.	138
20	Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes	Annals of Neurology	Charles A. Thornton, Keith Johnson et al.	219

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact